Skip to content

Role of Nidana Parivarjana And Prakriti Vighata in Shleshmaja Krimi

Aetiopathological Study And Therapeutic Evaluation of Nidana Parivarjana And Prakriti Vighata in Shleshmaja Krimi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027250
Enrollment
100
Registered
2020-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B779- Ascariasis, unspecified

Interventions

Intervention1: Albendazole and starch capsules: Single dose of Tab Albendazole 400mg HS and then Starch cap 1HS for 2 & half months. Control Intervention1: Albendazole & Prakriti Vighatakar yog: singl

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Shleshmaja Krimi roga. Patients with positive stool examination for intestinal helminths.

Exclusion criteria

Exclusion criteria: Patients of age group less than 5 years and more than 30 years. Patients having Krimi roga other than Shleshmaja Krimi roga. Patients with negative stool examination for intestinal helminths. Known cases of Neurocysticercosis and intestinal obstruction due to intestinal helminths. Patients suffering from various debilitating systemic disorders like Diabetes Mellitus and other complicated systemic disorders.

Design outcomes

Primary

MeasureTime frame
Assessment of Shleshmaja Krimi rog will be done on the basis of subjective and objective criteriaTimepoint: 2 months 15 days

Secondary

MeasureTime frame
Role of Nidana Parivarjana and Prakriti Vighat will evaluated in arresting the recurrence rate of Shleshmaja Krimi rogTimepoint: 2 months 15 days

Countries

India

Contacts

Public ContactRashi Dhasmana

Rishikul Campus, Uttarakhand Ayurved University, Haridwar

drsanjaysingh1970@gmail.com7060754892

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026